Royce & Associates’s Teladoc Health TDOC Stock Holding History

Royce & Associates’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-18,189	Closed	-$167K	–	902
2024 Q3	$167K	Buy	+18,189	New	+$151K	﹤0.01%	839

Other funds holding TDOC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MRCP

Maple Rock Capital Partners Toronto, Ontario, Canada $3.07B AUM 157.2% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Royce & Associates's TDOC Position: Q4 2024 in Review

Royce & Associates sold out of Teladoc Health (TDOC) in Q4 2024, closing a stake of 18,189 shares — an estimated $167K sold.

Royce & Associates first reported a position in TDOC in Q3 2024 and held it in 1 quarter. The position peaked at $167K in Q3 2024. 380 funds tracked by Wall St. Rank hold TDOC as of Q4 2024.

Royce & Associates reported no remaining Teladoc Health position as of Q4 2024 after selling out during the quarter.
Royce & Associates sold 18,189 Teladoc Health shares in Q4 2024, an estimated $167K.
Royce & Associates first reported a position in Teladoc Health in Q3 2024 and held it in 1 quarter.
Royce & Associates's Teladoc Health position peaked at $167K in Q3 2024.
380 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2024.

Based on Royce & Associates's 13F filing for Q4 2024, filed 10 Feb 2025.